
Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇦🇺AU · Medicine#1605K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
1.5K to 9K🎙 Daily cadence·65 episodes·Last published 2w ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇦🇺100% - Active Followers
Loyal subscribers who consistently listen
2K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
From Idea to Market: Ep 10 - What Breaks at Scale
May 22, 2026
32m 08s
FITM Extended Interview: Alexander Sah
May 19, 2026
23m 23s
From Idea to Market: Ep 9 - Inside the Decision Room
May 15, 2026
33m 17s
FITM Extended Interview: Charles Lawrie (FIOS Health)
May 12, 2026
31m 55s
From Idea to Market: Ep 8 - Built to Run
May 8, 2026
38m 49s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/22/26 | ![]() From Idea to Market: Ep 10 - What Breaks at Scale | Send us Fan Mail What real-world use reveals about a medical device that no clinical trial ever could — and why the most dangerous moment in med tech innovation often comes after success, not before. A conversation about the fatigue failures, reimbursement gaps, and feedback breakdowns that surface only at scale. For ten episodes, the From Idea to Market series has followed medical innovation through every threshold an idea must survive — the first clinical insight, the years of iteration, t... | 32m 08s | ||||||
| 5/19/26 | ![]() FITM Extended Interview: Alexander Sah | Send us Fan Mail Alex Sah on what it actually takes for a practicing surgeon to develop new orthopaedic tools — from first idea to OR adoption. An honest conversation about mentors, mistakes, AI, and knowing when to walk away from a collaboration. Most surgeons spot problems in the OR daily and quietly adapt to the limits of existing tools. Alex Sah, a high-volume hip and knee surgeon in Silicon Valley and Chief Medical Officer at Think Surgical, has chosen instead to engage directly with i... | 23m 23s | ||||||
| 5/15/26 | ![]() From Idea to Market: Ep 9 - Inside the Decision Room | Send us Fan Mail What med tech investors and strategic acquirers actually evaluate when a founder walks into the room — and what separates the pitches that earn capital from those that don't. A conversation drawn from people who've sat on both sides of the table. For nine episodes, the From Idea to Market series has followed innovation from the founder's perspective — the problem noticed in a clinic, the iteration through years of prototypes, the regulatory climb, the manufacturing scale-up. ... | 33m 17s | ||||||
| 5/12/26 | ![]() FITM Extended Interview: Charles Lawrie (FIOS Health) | Send us Fan Mail Charles Lawrie, MD — president of the Anterior Hip Foundation and a high-volume anterior approach hip and robotic knee surgeon in Miami — walks us through how a frustration in his own clinic became FIOS Health, an AI-powered patient communication platform now used in orthopaedic practices across the United States. This is an extended From Idea to Market conversation about the often lonely process of turning a clinical observation into a commercialized med-tech product, and wh... | 31m 55s | ||||||
| 5/8/26 | ![]() From Idea to Market: Ep 8 - Built to Run | Send us Fan Mail What does it actually take to move a medical device from a working prototype to a product that can be built reliably at volume? In this episode of From Idea to Market, surgeons, founders, and attorneys describe the discipline that separates an approved device from a scalable company. Most medical device teams underestimate what happens after a prototype works. Manufacturing at scale is a different problem from manufacturing at all, and the assumption that the hard work is do... | 38m 49s | ||||||
| 5/1/26 | ![]() FITM Extended Interview: Emily Ast | Send us Fan Mail There is no such thing as an off-the-record innovation discussion. Even a casual conversation over drinks can create a factual record of idea sharing that impacts patent ownership, joint development leverage, and your negotiating position for years. Emily Ast, a contract attorney whose practice is 75 percent orthopedics, explains exactly what surgeon innovators need to know before they say a word to anyone — including friends and family. Ast breaks down the two main contract... | 35m 01s | ||||||
| 4/28/26 | ![]() FITM Extended Interview: XRS Medical (Marie-Isabelle Batthyány) | Send us Fan Mail A patient had already signed every document — but no one had told her she would lose her stomach. That moment early in her anesthesia training convinced Marie-Isabelle Batthyány that informed consent was fundamentally broken. Years later, she built XRS Medical, a VR platform that replaces paper consent forms with immersive, avatar-delivered patient education and tracks attention in real time using a patented eye-tracking algorithm. Batthyány walks through exactly what happen... | 48m 42s | ||||||
| 4/24/26 | ![]() FITM Extended Interview: Simon Mifsud (Garland Surgical, Ltd.) | Send us Fan Mail Garland Surgical's flagship product, the TriActiv Hip (formerly known as the MaltaHip), replaces the ball-and-socket geometry that has defined hip arthroplasty for 120 years with a cylindrical bearing system inspired by the biomechanics of the ankle joint. Simon Mifsud, CEO of Garland Surgical, explains how this design virtually eliminates dislocation risk and reduced wear by 75 percent in accelerated testing. Mifsud walks through how the cylindrical design achieves its stab... | 35m 31s | ||||||
| 4/17/26 | ![]() From Idea to Market: Ep 7 - Beyond Clearance | Send us Fan Mail Your device just got FDA clearance. So why isn't anyone using it? In this episode of From Idea to Market, Joe Schwab and a panel of surgeons, engineers, and MedTech leaders explore why regulatory approval is only the beginning — and what it actually takes to earn a place in the operating room. Clearance tells you a device is safe and effective. It doesn't tell you whether a busy surgeon will change their workflow, whether a procurement committee will approve it, or whether a... | 40m 26s | ||||||
| 4/14/26 | ![]() FITM Extended Interview: Charlie DeCook | Send us Fan Mail Charlie DeCook has exited seven medical device companies while performing 1,500 joint replacements a year — all packed into three clinical days per week. In this extended interview, he breaks down exactly how he evaluates new technologies and why he now filters every opportunity through an AI and robotics lens. DeCook traces his entrepreneurial arc from his first venture in surgical impaction — a product that eventually sold to Johnson & Johnson and became Kincise — thro... | 29m 44s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 4/10/26 | ![]() From Idea to Market: Ep 6 - The Valley Between Idea and Approval | Send us Fan Mail What actually happens between building a medical device and getting it approved? In this episode of From Idea to Market, we walk through the regulatory valley that separates a working prototype from a cleared product — and why so many promising innovations stall right here. This is the stage where progress stops being about what you can build and starts being about what you can prove. Joe Schwab breaks down the FDA's device classification system, the critical difference betw... | 26m 43s | ||||||
| 4/7/26 | ![]() FITM: The Extended Conversation with Doug Fairbanks | Send us Fan Mail Doug Fairbanks left a robotics commercialization role at Johnson & Johnson to lead a deep tech startup most surgeons had never heard of. In this conversation, the president and CEO of VISIE Inc. explains why — and what their continuous anatomic auto tracking technology could mean for the future of robotic-assisted surgery. VISIE started as Advanced Scanners, a company founded by optical physicist Aaron Bernstein to solve the problem of brain shift during cranial procedur... | 43m 26s | ||||||
| 4/3/26 | ![]() From Idea to Market: Ep 5 - Financing the Journey | Send us Fan Mail Most MedTech founders think financing is about getting enough money to keep building. But once you take capital, it reshapes your governance, your priorities, and your pace — and some consequences don't surface for years. In this episode of the AHF Podcast's From Idea to Market series, we explore what funding actually buys beyond time and resources, how capital decisions redistribute power within a startup, and which financing consequences only become visible years later. Fou... | 27m 38s | ||||||
| 3/31/26 | ![]() FITM: The Full Conversation with Robert Cohen | Send us Fan Mail Robert Cohen has spent four decades on both sides of the MedTech table — founding companies, selling them, and now evaluating billion-dollar acquisitions as Stryker's VP of Innovation and Technology for Orthopedics. In this conversation, he shares exactly what a global company looks for when it decides whether a startup's technology is worth acquiring. Cohen's career reads like a timeline of modern orthopedic innovation. He co-founded Implex, the company behind trabecular me... | 43m 58s | ||||||
| 3/27/26 | ![]() The Team Behind the Surgeon: Efficiency Lessons From Canada | Send us Fan Mail Dr. Sebastian Rodriguez-Elizalde built a same-day anterior hip program inside a Canadian public hospital — not a private surgical center. This conversation covers what it actually takes to change your approach, your team culture, and your system all at once. Sebastian trained in posterior approach at HSS and transitioned to anterior approach early in his independent career. In this episode, he talks honestly about the ego hit of relearning something you were already good at,... | 52m 30s | ||||||
| 3/24/26 | ![]() FITM: The Full Conversation with ForCast Orthopedics | Send us Fan Mail This is a deep-dive extended interview with the team behind ForCast Orthopedics — a company working to change how periprosthetic joint infection is treated. It's for orthopedic surgeons, arthroplasty specialists, and anyone interested in how a clinical idea becomes a medical device company. The conversation brings together Dr. Jared Foran (CSO and co-founder), Dr. Leo Whiteside (the surgeon whose intraarticular infusion technique underlies the product), and Peter Noymer (CEO... | 46m 10s | ||||||
| 3/20/26 | ![]() From Idea to Market: Ep 4 - Choosing the Vehicle | Send us Fan Mail This episode is about the moment an idea needs a formal structure to move forward — and why that choice is just as strategic as any technical decision. It's for clinician innovators, med tech founders, and anyone trying to understand how organizational structure shapes what an innovation can realistically become. The episode draws on voices from across the From Idea to Market series — surgeons, engineers, attorneys, and executives — to explore three questions: what determine... | 25m 31s | ||||||
| 3/13/26 | ![]() From Idea to Market: Ep 3 - Proof of Concept | Send us Fan Mail This episode explores what proof of concept really means in medical device development — and why the hardest problems at this stage are rarely technical. It's for clinician innovators, engineers, and anyone navigating the gap between a promising idea and a product that can survive the real world. The episode draws on perspectives from surgeons, engineers, and founders across multiple active med tech ventures. Together they walk through three questions that define this stage: ... | 24m 41s | ||||||
| 3/6/26 | ![]() How AI is Personalizing Hip Replacement Care | Send us Fan Mail Dr. Kristoff Corten built an AI-driven platform called Hip Cloud that predicts patient outcomes after hip replacement — and it's changing the way he practices. If you're an orthopedic surgeon interested in how predictive analytics, personalized care pathways, and clinic efficiency can reshape your workflow, this conversation is for you. In this episode, Joe Schwab sits down with Belgian orthopedic surgeon and entrepreneur Kristoff Corten to explore how he went from feeling bo... | 46m 50s | ||||||
| 2/27/26 | ![]() From Idea to Market: Ep 2 - Shaping the Idea | Send us Fan Mail This episode explores how orthopedic innovators determine whether a clinical problem is worth solving at scale. We examine the transition from recognizing a frustration in practice to building a defensible business case for medical device development. Featuring perspectives from surgeons, CEOs, engineers, and legal experts, this conversation unpacks the critical questions that separate ideas worth pursuing from those destined to fail. We discuss burden arbitrage in periprost... | 25m 56s | ||||||
| 2/20/26 | ![]() From Idea to Market: Ep 1 - The Spark | Send us Fan Mail This episode explores how medical innovation actually begins—not in labs or boardrooms, but in operating rooms, clinics, and patient encounters where routine practice no longer feels acceptable. We speak with orthopedic surgeons, engineers, and founders who've lived the journey from clinical frustration to real-world solutions. Innovation doesn't start with a breakthrough moment. It starts when someone notices the same problem repeatedly and decides they can't look away. Thro... | 24m 51s | ||||||
| 2/11/26 | ![]() From Idea to Market: A New Series on Innovation | Send us Fan Mail This mini-series explores how medical innovation actually happens in practice—from the first spark of an idea to bringing a product to market. Whether you're a surgeon, engineer, researcher, or trainee with an idea, this series shows you what comes next. We've gathered surgeons, engineers, CEOs, attorneys, and innovators who have navigated this journey firsthand. They share insights on developing medical devices, navigating regulatory pathways, building companies, and transla... | 2m 11s | ||||||
| 1/30/26 | ![]() The Anterior Hip Learning Curve Nobody Warns You About | Send us Fan Mail Learning the anterior approach to total hip arthroplasty doesn't follow a straight line. Dr. Joe Schwab shares what happened when improving his femoral technique unexpectedly made his acetabular work feel worse—and why that unsettling experience taught him more than any single complication. This episode is for orthopedic surgeons and trainees navigating the anterior approach learning curve, especially those who feel like their progress isn't linear. Joe walks through his own ... | 20m 59s | ||||||
| 1/23/26 | ![]() Ask Me Anything: LFCN Issues | Send us Fan Mail An engaging, AMA‑style deep dive into how to actually manage lateral femoral cutaneous nerve problems after anterior approach THA—from “my thigh feels weird” numbness to true neuroma‑level pain that drives patients crazy. In this Ask Me Anything episode, host Joe Schwab answers a real listener question from Dr. Tim Keating: “What is your treatment algorithm for patients with LFCN dysesthesia, neuroma, and other lasting bothersome effects?” Drawing on both the meralgia paresth... | 21m 02s | ||||||
| 1/16/26 | ![]() Rethinking TFL Injury in Anterior Approach THA | Send us Fan Mail Protecting the Tensor Fascia Lata in Anterior Approach Total Hip Arthroplasty 🎥 Welcome to the AHF Podcast! Join host Joe Schwab as he dives deep into a revealing and award-winning study on tensor fascia lata (TFL) injury during anterior approach total hip arthroplasty with special guest H. John Cooper. Dr. Cooper shares insights from his prospective study presented at the 2025 AHF annual meeting, discussing how often TFL injuries occur, the critical steps to minimize such i... | 41m 01s | ||||||
Showing 25 of 73
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.
